Skip to main content
Top
Published in: Internal and Emergency Medicine 7/2019

01-10-2019 | Heart Failure | IM - ORIGINAL

Right ventricular diameter predicts all-cause mortality in heart failure with preserved ejection fraction

Authors: Gaspare Parrinello, Daniele Torres, Silvio Buscemi, Tiziana Di Chiara, Francesco Cuttitta, Mauro Cardillo, Francesca Romana Pluchinotta, Rosario Scaglione, Salvatore Paterna, Antonio Pinto

Published in: Internal and Emergency Medicine | Issue 7/2019

Login to get access

Abstract

Left ventricular ejection fraction (EF) is helpful to differentiate heart failure (HF) phenotype in clinical practice. The aim of the study was to identify simple echocardiographic predictors of post-discharge all-cause mortality in hospitalized HF patients. Patients with acute HF (75 ± 9.8 years), classified in preserved (≥ 50%) and reduced (< 50%) EF (HFpEF and HFrEF, respectively), were enrolled. The mean follow-up period was of 25.4 months. Patients definitively analyzed were 135. At multivariate Cox model, right ventricular diameter (RVd), inferior vena cava diameter (IVCd) and blood urea nitrogen (BUN) resulted to be significantly associated with all-cause mortality in HFpEF (HR 2.4, p = 0.04; HR 1.06, p = 0.02; HR 1.02, p = 0.01), whereas, left atrial volume (LAV) was significantly associated with mortality in HFrEF (HR 1.06, p = 0.006). Excluding LAV from the model, only COPD remained an independent predictor of all-cause mortality (HR 2.15, p = 0.04) in HFrEF. At Kaplan–Meier analysis, no differences of survival between HFrEF and HFpEF were found, however, significantly increased all-cause mortality for higher values of basal-RVd, BUN, and IVCd (log-rank p = 0.0065, 0.0063, 0.0005) in HFpEF, and for COPD and higher LAV (log-rank p = 0.0046, p = 0.033) in HFrEF. These data are indicative that in patients hospitalized with HF, EF is not a suitable predictor of long-term all-cause mortality, whereas, right ventricular volumetric remodeling and IVCd have a prognostic role in HFpEF as well as LAV in HFrEF. Our study suggests that besides EF, other echocardiographic parameters are helpful to optimize the phenotyping and prognostic stratification of HF.
Literature
1.
go back to reference Murphy SL, Xu JQ, Kochanek KD (2013) Deaths: final data for 2010. National vital statics reports, vol 61. National Center for Health Statistics, Hyattsville, p 2013 Murphy SL, Xu JQ, Kochanek KD (2013) Deaths: final data for 2010. National vital statics reports, vol 61. National Center for Health Statistics, Hyattsville, p 2013
3.
go back to reference Zakeri R, Mohammed SF (2015) Epidemiology of right ventricular dysfunction in heart failure with preserved ejection fraction. Curr Heart Fail Rep 12(5):295–301CrossRefPubMed Zakeri R, Mohammed SF (2015) Epidemiology of right ventricular dysfunction in heart failure with preserved ejection fraction. Curr Heart Fail Rep 12(5):295–301CrossRefPubMed
4.
go back to reference McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K et al (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Eur Heart J 33:1787–1847CrossRefPubMed McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K et al (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Eur Heart J 33:1787–1847CrossRefPubMed
5.
go back to reference Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, Hahn RT, Han Y, Hung J, Lang RM, Little SH, Shah DJ, Shernan S, Thavendiranathan P, Thomas JD, Weissman NJ (2017) Recommendations for noninvasive evaluation of native valvular regurgitation a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 30(4):303–371CrossRef Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, Hahn RT, Han Y, Hung J, Lang RM, Little SH, Shah DJ, Shernan S, Thavendiranathan P, Thomas JD, Weissman NJ (2017) Recommendations for noninvasive evaluation of native valvular regurgitation a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 30(4):303–371CrossRef
6.
go back to reference Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28(1):1–39.e14CrossRefPubMed Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28(1):1–39.e14CrossRefPubMed
7.
go back to reference Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, ESC Scientific Document Group (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129–2200CrossRef Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, ESC Scientific Document Group (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129–2200CrossRef
8.
go back to reference Fonarow GC (2008) Epidemiology and risk stratification in acute heart failure. Am Heart J 155(2):200–207CrossRefPubMed Fonarow GC (2008) Epidemiology and risk stratification in acute heart failure. Am Heart J 155(2):200–207CrossRefPubMed
9.
go back to reference Aronson D, Mittleman MA, Burger AJ (2004) Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure. Am J Med 116:466–473CrossRefPubMed Aronson D, Mittleman MA, Burger AJ (2004) Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure. Am J Med 116:466–473CrossRefPubMed
10.
go back to reference Filippatos G, Rossi J, Lloyd-Jones DM, Stough WG, Ouyang J, Shin DD, O’connor C, Adams KF, Orlandi C, Gheorghiade M (2007) Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the acute and chronic therapeutic impact of a vasopressin antagonist in chronic heart failure (ACTIV in CHF) study. J Card Fail 13:360–364CrossRefPubMed Filippatos G, Rossi J, Lloyd-Jones DM, Stough WG, Ouyang J, Shin DD, O’connor C, Adams KF, Orlandi C, Gheorghiade M (2007) Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the acute and chronic therapeutic impact of a vasopressin antagonist in chronic heart failure (ACTIV in CHF) study. J Card Fail 13:360–364CrossRefPubMed
11.
go back to reference Cauthen CA, Lipinski MJ, Abbate A, Appleton D, Nusca A, Varma A, Goudreau E, Cowley MJ, Vetrovec GW (2008) Relation of blood urea nitrogen to long-term mortality in patients with heart failure. Am J Cardiol 101:1643–1647CrossRefPubMed Cauthen CA, Lipinski MJ, Abbate A, Appleton D, Nusca A, Varma A, Goudreau E, Cowley MJ, Vetrovec GW (2008) Relation of blood urea nitrogen to long-term mortality in patients with heart failure. Am J Cardiol 101:1643–1647CrossRefPubMed
12.
go back to reference Parrinello G, Torres D, Testani JM et al (2015) Blood urea nitrogen to creatinine ratio is associated with congestion and mortality in heart failure patients with renal dysfunction. Intern Emerg Med 10(8):965–972CrossRefPubMed Parrinello G, Torres D, Testani JM et al (2015) Blood urea nitrogen to creatinine ratio is associated with congestion and mortality in heart failure patients with renal dysfunction. Intern Emerg Med 10(8):965–972CrossRefPubMed
13.
go back to reference Kazory A (2010) Emergence of blood urea nitrogen as a biomarker of neurohormonal activation in heart failure. Am J Cardiol 106(5):694–700CrossRefPubMed Kazory A (2010) Emergence of blood urea nitrogen as a biomarker of neurohormonal activation in heart failure. Am J Cardiol 106(5):694–700CrossRefPubMed
14.
go back to reference Ferrara F, Gargani L, Ostenfeld E, D’Alto M, Kasprzak J, Voilliot D, Selton-Suty C, Vriz O, Marra AM, Argiento P, Stanziola AA, Cittadini A, D’Andrea A, Bossone E (2017) Imaging the right heart pulmonary circulation unit: insights from advanced ultrasound techniques. Echocardiography 34(8):1216–1231CrossRefPubMed Ferrara F, Gargani L, Ostenfeld E, D’Alto M, Kasprzak J, Voilliot D, Selton-Suty C, Vriz O, Marra AM, Argiento P, Stanziola AA, Cittadini A, D’Andrea A, Bossone E (2017) Imaging the right heart pulmonary circulation unit: insights from advanced ultrasound techniques. Echocardiography 34(8):1216–1231CrossRefPubMed
15.
go back to reference Gorter TM, Hoendermis ES, van Veldhuisen DJ et al (2016) Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta-analysis. Eur J Heart Fail 18(12):1472–1487CrossRefPubMed Gorter TM, Hoendermis ES, van Veldhuisen DJ et al (2016) Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta-analysis. Eur J Heart Fail 18(12):1472–1487CrossRefPubMed
16.
go back to reference Haddad F, Doyle R, Murphy DJ, Hunt SA (2008) Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation 117:1717–1731CrossRefPubMed Haddad F, Doyle R, Murphy DJ, Hunt SA (2008) Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation 117:1717–1731CrossRefPubMed
17.
go back to reference Katz DH, Burns JA, Aguilar FG, Beussink L, Shah SJ (2014) Albuminuria is independently associated with cardiac remodeling, abnormal right and left ventricular function, and worse outcomes in heart failure with preserved ejection fraction. JACC Heart Fail 2:586–596CrossRefPubMedPubMedCentral Katz DH, Burns JA, Aguilar FG, Beussink L, Shah SJ (2014) Albuminuria is independently associated with cardiac remodeling, abnormal right and left ventricular function, and worse outcomes in heart failure with preserved ejection fraction. JACC Heart Fail 2:586–596CrossRefPubMedPubMedCentral
18.
go back to reference Paulus WJ, Tschope C (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62:263–271CrossRefPubMed Paulus WJ, Tschope C (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62:263–271CrossRefPubMed
19.
go back to reference Sano M, Minamino T, Toko H et al (2007) p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 446:444–448CrossRefPubMed Sano M, Minamino T, Toko H et al (2007) p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 446:444–448CrossRefPubMed
20.
go back to reference Vonk Noordegraaf A, Westerhof BE, Westerhof N (2017) The Relationship between the right ventricle and its load in pulmonary hypertension. J Am Coll Cardiol 69(2):236–243CrossRefPubMed Vonk Noordegraaf A, Westerhof BE, Westerhof N (2017) The Relationship between the right ventricle and its load in pulmonary hypertension. J Am Coll Cardiol 69(2):236–243CrossRefPubMed
21.
go back to reference Triposkiadis F, Pieske B, Butler J et al (2016) Global left atrial failure in heart failure. Eur J Heart Fail 18(11):1307–1320CrossRefPubMed Triposkiadis F, Pieske B, Butler J et al (2016) Global left atrial failure in heart failure. Eur J Heart Fail 18(11):1307–1320CrossRefPubMed
22.
go back to reference Cameli M, Mandoli GE, Mondillo S (2017) Left atrium: the last bulwark before overt heart failure. Heart Fail Rev 22(1):123–131CrossRefPubMed Cameli M, Mandoli GE, Mondillo S (2017) Left atrium: the last bulwark before overt heart failure. Heart Fail Rev 22(1):123–131CrossRefPubMed
23.
go back to reference Stefanadis C, Dernellis J, Toutouzas P (2001) A clinical appraisal of left atrial function. Eur Heart J 22:22–36CrossRefPubMed Stefanadis C, Dernellis J, Toutouzas P (2001) A clinical appraisal of left atrial function. Eur Heart J 22:22–36CrossRefPubMed
24.
go back to reference Triposkiadis F, Harbas C, Kelepeshis G et al (2007) Left atrial remodeling in patients younger than 70 years with diastolic and systolic heart failure. J Am Soc Echocardiogr 20:177–185CrossRefPubMed Triposkiadis F, Harbas C, Kelepeshis G et al (2007) Left atrial remodeling in patients younger than 70 years with diastolic and systolic heart failure. J Am Soc Echocardiogr 20:177–185CrossRefPubMed
25.
go back to reference Melenovsky V, Hwang SJ, Redfield MM et al (2015) Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction. Circ Heart Fail 8:295–303CrossRefPubMed Melenovsky V, Hwang SJ, Redfield MM et al (2015) Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction. Circ Heart Fail 8:295–303CrossRefPubMed
26.
go back to reference Quinones MA, Greenberg BH, Kopelen HA et al (2000) Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of left ventricular dysfunction. J Am Coll Cardiol 35:1237–1244CrossRefPubMed Quinones MA, Greenberg BH, Kopelen HA et al (2000) Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of left ventricular dysfunction. J Am Coll Cardiol 35:1237–1244CrossRefPubMed
27.
go back to reference Rossi A, Temporelli PL, Quintana M et al (2009) MeRGE heart failure collaborators. independent relationship of left atrial size and mortality in patients with heart failure: an individual patient meta-analysis of longitudinal data (MeRGE heart failure). Eur J Heart Fail 11:929–936CrossRefPubMed Rossi A, Temporelli PL, Quintana M et al (2009) MeRGE heart failure collaborators. independent relationship of left atrial size and mortality in patients with heart failure: an individual patient meta-analysis of longitudinal data (MeRGE heart failure). Eur J Heart Fail 11:929–936CrossRefPubMed
28.
go back to reference Casaclang-Verzosa G, Gersh BJ, Tsang TS (2008) Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J Am Coll Cardiol 51:1–11CrossRefPubMed Casaclang-Verzosa G, Gersh BJ, Tsang TS (2008) Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J Am Coll Cardiol 51:1–11CrossRefPubMed
29.
go back to reference Dzeshka MS, Lip GY, Snezhitskiy V, Shantsila E (2015) Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications. J Am Coll Cardiol 66:943–959CrossRefPubMed Dzeshka MS, Lip GY, Snezhitskiy V, Shantsila E (2015) Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications. J Am Coll Cardiol 66:943–959CrossRefPubMed
31.
go back to reference Weber KT, Sun Y, Bhattacharya SK et al (2013) Myofibroblastmediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol 10:15CrossRef Weber KT, Sun Y, Bhattacharya SK et al (2013) Myofibroblastmediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol 10:15CrossRef
Metadata
Title
Right ventricular diameter predicts all-cause mortality in heart failure with preserved ejection fraction
Authors
Gaspare Parrinello
Daniele Torres
Silvio Buscemi
Tiziana Di Chiara
Francesco Cuttitta
Mauro Cardillo
Francesca Romana Pluchinotta
Rosario Scaglione
Salvatore Paterna
Antonio Pinto
Publication date
01-10-2019
Publisher
Springer International Publishing
Keyword
Heart Failure
Published in
Internal and Emergency Medicine / Issue 7/2019
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-019-02071-x

Other articles of this Issue 7/2019

Internal and Emergency Medicine 7/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine